Phase 2 Metastatic Triple-negative Breast Cancer Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Saci Nivo Rela for TNBC
Metastatic Triple-negative Breast Cancer
Yale University60 enrolled1 locationNCT06963905
Recruiting
Phase 1Phase 2
Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)
Metastatic Triple-negative Breast Cancer
M.D. Anderson Cancer Center31 enrolled1 locationNCT07011654
Recruiting
Phase 2
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Breast CancerMetastatic Triple-negative Breast Cancer
Memorial Sloan Kettering Cancer Center55 enrolled10 locationsNCT05570253
Recruiting
Phase 2
The Clinical Study of the Efficacy and Safety of Trop2-ADC Monotherapy or Combination Immunotherapy Strategy in the Treatment of Advanced Triple-negative Breast Cancer.
Metastatic Triple-negative Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University60 enrolled1 locationNCT06851299